–
Alto Neuroscience, Inc.
Metrics score locked — part of Premium
FY21
FY22
FY23
FY24
FY25
FY21 – FY25
(positive)
Change from FY23 to FY25
millions USD
FY21:
FY22:
–
FY23:
−33.4
FY24:
−47.4
FY25:
−51.8
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
−0.47
FY24:
−2.08
FY25:
−0.02
Change from FY23 to FY25
millions USD
FY21:
–
FY22:
–
FY23:
68.1
FY24:
136
FY25:
60.1
millions USD
FY21:
–
FY22:
–
FY23:
34.2
FY24:
86.2
FY25:
8.26
(positive)
Change from FY21 to FY25
millions USD
FY21:
−9.94
FY22:
−21.1
FY23:
−33.9
FY24:
−49.5
FY25:
−51.8
All amounts in millions USD FY21, FY22: figures supplemented from Twelve Data because the SEC filings do not reach back this far.